Could a simple device ease nerve pain in Charcot-Marie-Tooth?
NCT ID NCT01918826
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested whether a TENS device, which sends mild electrical pulses through the skin, can reduce leg pain in people with Charcot-Marie-Tooth disease. Ten adults with chronic pain participated. The goal was to see if pain scores dropped by at least 30%.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- TENS (transcutaneous electrical nerve stimulation) device
- What this could lead to
- If it works, this could offer a drug-free, low-risk way to manage chronic pain in Charcot-Marie-Tooth disease.
- What could go wrong
- This is a very small, early study with only 10 participants, so results may not apply to everyone. Pain relief may be minimal or not last.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
10 people
The number who actually took part.
- Started
-
Aug 2012
- Finished
-
Jul 2014
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 75 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Age included between 18 and 75 years * Affected by CMT confirmed on clinical, family criteria, electrophysiological and / or genetics * pain ≥ 3 months * EVA pain ≥ 4/10 * patient having given his written consent and lit(enlightened) * patient susceptible to be followed regularly during at least 3 months * Patient member to the Social Security Exclusion Criteria: * Expanding patients of associated neurological pathology * Patients having resorted to the TENS in the last 3 months * Medical history of cancers, collagen and quite other pathology which can interfere with the experimental procedure * Patient carrier of a pacemaker or an active implantable medical device * Cutaneous hurt on the territory to be stimulated * Venous or arterial thrombosis or thrombophlebitis in the territory to be stimulated * Patient participant in another biomedical research on the pain or the period of exclusion of which in a study is not ended * Patient under guardianship or deprived of all his liberties
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Charcot-Marie-Tooth disease are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CHU de Nice
Nice, 06000, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Global registry aims to map the full course of Charcot-Marie-Tooth disease
- Could a simple blood test track nerve damage? a study investigates NT-3 levels in neuropathy.
- Gene study aims to decode rare nerve disorder variations
- CMT tremor mystery: new study aims to uncover hidden symptoms
- Wearable tech tracks fatigue in muscle disease patients
- New fabric brace could give arm strength back to patients with muscle diseases